2 result(s) displayed (1 - 2 of 2):
It didn't hire anyone to seek strategic alternatives, but Baxter International Inc. (NYSE:BAX) is seen by some as a likely acquisition target, especially after Abbott Laboratories (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ) boosted their vaccines pipelines. Abbott is paying €4.5 billion ($6.6 billion) for the pharmaceutical activities of Belgium's...
Posted on September 30, 2009 2:47 PM
No doubt about it: Corporate development is different from investment banking -- notwithstanding the fact that many corporate development job postings list i-banking experience as a desirable qualification. Folks who make the switch don't do it for the money. They do sometimes do it for quality-of-life reasons, or for the...
Posted on June 24, 2008 2:06 PM
Movable Type search results powered by Fast Search